Dexamfetamine, a psychostimulant , is heavily monitored in Australia because of its misuse potential. Its usage is primarily limited to treatment of attention-deficit hyperactivity disorder (ADHD) in patients and, infrequently , for excessive daytime sleepiness . Scripts for dexamfetamine are tig